Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fishman

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Gynecologic Oncology|September 28, 2020
Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitalsMelissa K Frey, Rana K Fowlkes, Nora M Badiner, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Nature Communications|January 8, 2014
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transitionAditya Parikh, Christine Lee, Peronne Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Clinical Chemistry|April 28, 2007
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samplesMary F Lopez, Alvydas Mikulskis, Scott Kuzdzal, et al.
Cancer Treatment and Research|January 5, 2002
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancerGordon B Mills, Astrid Eder, Xianjun Fang, et al.
Cancer Research|January 21, 2006
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arraysMadhumita Chatterjee, Saroj Mohapatra, Alexei Ionan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu, Andrea P Patterson, Lin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Gynecologic Oncology|September 28, 2020
Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitalsMelissa K Frey, Rana K Fowlkes, Nora M Badiner, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Nature Communications|January 8, 2014
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transitionAditya Parikh, Christine Lee, Peronne Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Clinical Chemistry|April 28, 2007
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samplesMary F Lopez, Alvydas Mikulskis, Scott Kuzdzal, et al.
Cancer Treatment and Research|January 5, 2002
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancerGordon B Mills, Astrid Eder, Xianjun Fang, et al.
Cancer Research|January 21, 2006
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arraysMadhumita Chatterjee, Saroj Mohapatra, Alexei Ionan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu, Andrea P Patterson, Lin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Pageof 4